Jan Schultess

Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays

Eva Sickinger, Françoise Gay‐Andrieu, Gesa Jonas et al. · Diagnostic Microbiology and Infectious Disease · 2008 · 57 citations

Pharmacy, Bioengineering, Analytical Chemistry +8

Development of Fully Automated Determination of Marker-Specific Immunoglobulin G (IgG) Avidity Based on the Avidity Competition Assay Format: Application for Abbott Architect Cytomegalovirus and Toxo IgG Avidity Assays

Ingo Curdt, Gerald Praast, Eva Sickinger et al. · Journal of Clinical Microbiology · 2009 · 37 citations

Life Sciences, Infectious Diseases, Microbiology +17

Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay

Mary C. Kuhns, Vera Holzmayer, Anne L. McNamara et al. · Journal of Clinical Virology · 2019 · 25 citations · Full text

Medicine, Infectious Diseases, Molecular Biology +17

Interlaboratory comparison of 25-hydroxyvitamin D assays: Vitamin D Standardization Program (VDSP) Intercomparison Study 2 — Part 2 ligand binding assays — impact of 25-hydroxyvitamin D2 and 24R,25-dihydroxyvitamin D3 on assay performance

Stephen A. Wise, Johanna E Camara, Carolyn Q Burdette et al. · Analytical and Bioanalytical Chemistry · 2021 · 23 citations · Full text

Life Sciences, Nutritional Sciences, Biopharmaceutics +13

Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2

Johanna E Camara, Stephen A. Wise, Andrew N. Hoofnagle et al. · Analytical and Bioanalytical Chemistry · 2021 · 21 citations · Full text

Medicine, Nutritional Sciences, Good Laboratory Practice +12